These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12775769)

  • 1. Breast cancer: when proteomics challenges biological complexity.
    Hondermarck H
    Mol Cell Proteomics; 2003 May; 2(5):281-91. PubMed ID: 12775769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics: challenges, techniques and possibilities to overcome biological sample complexity.
    Chandramouli K; Qian PY
    Hum Genomics Proteomics; 2009 Dec; 2009():. PubMed ID: 20948568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional proteomics of breast cancer for signal pathway profiling and target discovery.
    Hondermarck H; Dollé L; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Adriaenssens E; Lemoine J
    J Mammary Gland Biol Neoplasia; 2002 Oct; 7(4):395-405. PubMed ID: 12882524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of breast cancer: the quest for markers and therapeutic targets.
    Hondermarck H; Tastet C; El Yazidi-Belkoura I; Toillon RA; Le Bourhis X
    J Proteome Res; 2008 Apr; 7(4):1403-11. PubMed ID: 18311906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteomics of breast cancer: From differential to functional analysis].
    Hondermarck H
    J Soc Biol; 2006; 200(2):199-202. PubMed ID: 17151556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of breast cancer for marker discovery and signal pathway profiling.
    Hondermarck H; Vercoutter-Edouart AS; Révillion F; Lemoine J; el-Yazidi-Belkoura I; Nurcombe V; Peyrat JP
    Proteomics; 2001 Oct; 1(10):1216-32. PubMed ID: 11721634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of non-tumoral breast tissue.
    Costa GG; Kaviski R; Souza LE; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2011 Oct; 10(4):2430-42. PubMed ID: 21968807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of breast cancer: outcomes and prospects.
    El Yazidi-Belkoura I; Adriaenssens E; Vercoutter-Edouart AS; Lemoine J; Nurcombe V; Hondermarck H
    Technol Cancer Res Treat; 2002 Aug; 1(4):287-96. PubMed ID: 12625788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomics and breast cancer: new perspectives and limitations].
    Hondermarck H
    Pathol Biol (Paris); 2006 May; 54(4):194-8. PubMed ID: 16632259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions.
    Celis JE; Moreira JM; Cabezón T; Gromov P; Friis E; Rank F; Gromova I
    Mol Cell Proteomics; 2005 Apr; 4(4):492-522. PubMed ID: 15695426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
    Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
    Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
    Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
    Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of TGF-beta signaling and its impact on breast cancer.
    Souchelnytskyi S
    Expert Rev Proteomics; 2005 Dec; 2(6):925-35. PubMed ID: 16307521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Proteomics of Tumor and Paired Normal Breast Tissue Highlights Potential Biomarkers in Breast Cancer.
    Da Costa GG; Gomig TH; Kaviski R; Santos Sousa K; Kukolj C; De Lima RS; De Andrade Urban C; Cavalli IJ; Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(5):251-61. PubMed ID: 26417028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research.
    Head JE; Ring A
    Breast Cancer Res; 2003; 5(2):109-12. PubMed ID: 12631391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics: recent applications and new technologies.
    Elrick MM; Walgren JL; Mitchell MD; Thompson DC
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.
    Olsen L; Campos B; Winther O; Sgroi DC; Karger BL; Brusic V
    BMC Med Genomics; 2014; 7 Suppl 3(Suppl 3):S2. PubMed ID: 25521819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
    Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
    J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics for breast cancer urine biomarkers.
    Beretov J; Wasinger VC; Graham PH; Millar EK; Kearsley JH; Li Y
    Adv Clin Chem; 2014; 63():123-67. PubMed ID: 24783353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.